Patent

Proportion of Women Inventors on the Rise, Say Two New Studies


A brief while ago, I had published a piece on the interface between gender and IP. One of the key take- aways from the post was that the number of women patentees worldwide is extremely low as compared to men. Two recently published studies- one by the UK Intellectual Property Office (“Study 1”) and another, a working paper of WIPO (“Study 2”) – point out that the gender gap among inventors is slowly but surely being bridged across the world….


Read More »
Patent Plant Variety Protection

NSAI Writes to American Ambassador; Calls for Stringent Action Against Monsanto


On this Blog, we have extensively covered the Bt cotton saga involving Monsanto and Indian seed companies [see here, here, here, here and here]. The Indian seed companies have been represented in this legal struggle principally by the National Seeds Association of India (NSAI) whose strategy, aimed at freeing the commercializing of Bt cotton from the shackles imposed by Monsanto, was explained by Prashant with remarkable lucidity here. To briefly recapitulate, the NSAI argues that, while no one can cavil…


Read More »
Data Exclusivity Drug Regulation

Killing Me Softly: Of Data Exclusivity and Deadly Drugs!


In a recent post, Prashant took issue with the IPA’s contention that the Indian governments’ latest move to extend the moratorium for state drug regulatory approvals from 4 years to 10 years results in a long and damaging data exclusivity. Who is right? And who is wrong? Once one begins to trudge down this rabbit hole in search of answers, one realises that the alleged data exclusivity norm is the least of our worries. We have a far more deadly…


Read More »
Others

SpicyIP Weekly Review (November 20-26)


This week’s topical highlight doubtless has to be Prashant’s analysis of the Supreme Court’s recent order on the copyrightability of edited judgments. Prashant commences his analysis by alluding to an article in the Times of India which erroneously describes the order as creating new law. After briefly narrating the factual matrix of the case, Prashant briefly delineates the gravamen of the SC’s holding in the case of Eastern Book Company & others. v. DB Modak & Anr. Noting how the…


Read More »
Copyright

The Times of India gives a spin to a recent SC order on copyrightability of edited judgments


Earlier this week, the Times of India published a news report, by its legal correspondent Dhananjay Mahapatra regarding an appeal by Reeds Elseiver that was dismissed by the Supreme Court on November 23, 2016. Titled ‘No copyright over our judgments: SC’, the following are the opening paragraphs of Mahapatra’s report: For long, a couple of firms had a virtual monopoly over printing judgments of the Supreme Court in book format and selling it to advocates, institutions and others. So much…


Read More »
Others

Release of Justice Prabha Sridevan’s Book, ‘Of Vineyard Equality’


We are extremely pleased to bring to the notice of our readers that the book, ‘Of Vineyard Equality’, by Justice Prabha Sridevan was launched on Sunday, November 20, 2016 at the Inter University Centre for IPR Studies, CUSAT, Kochi. The press release on the launch of the book reads as follows: In the book she has compiled her thoughts and experiences that enthused and filled her with passion as the sitting judge at Madras High Court into a book which comprises…


Read More »
Others

SpicyIP Jobs: Max Planck Society India Office Manager in New Delhi


We are happy to announce that the Max Planck Society of Germany is looking for a New Delhi based Office Manager. The deadline for sending applications is November 30, 2016. About Max Planck Society The Max Planck Society is Germany’s most successful research organization. Since its establishment in 1948, no fewer than 18 Nobel laureates have emerged from the ranks of its scientists, putting it at par with the best and most prestigious research institutions worldwide. Currently, 83 Max Planck Institutes…


Read More »
Patent

Patent Office Rejects Patent Application for Prostate Cancer Drug Xtandi


Regular readers of this Blog will recall that, in his guest post on the topic of exorbitant drug pricing, Zakir Thomas had alluded to Xtandi (enzalutamide), a wonder drug developed at the University of California, Los Angeles (UCLA) for fighting prostate cancer which is commercially sold in India by Astellas Pharma. Noting how Astellas’ justification for the unaffordable cost of the drug viz. that it is commensurate with the cost of innovation and patient benefit is emblematic of the apathy…


Read More »
Biological Diversity

Bombay and Uttarakhand High Courts Clarify Points on Benefit Sharing under the Biological Diversity Act


Two recent orders from the High Courts of Bombay and Uttarakhand raise jurisdictional and substantive points relating to the benefit sharing mechanism provided for under the Biological Diversity Act, 2002 (‘BDA’) along with the Biodiversity Rules, 2004. Both cases discuss the alternative of taking the cases at hand to the National Green Tribunal (‘NGT’) instead, and examine its jurisdictional powers. Regular readers of the blog will recall our previous posts on the topic, but read here and here for some…


Read More »
Others

SpicyIP Weekly Review (November 13-19)


This week’s topical highlight was Prof. Shamnad’s insightful tribute to celebrated singer Leonard Cohen. Prof. Shamnad writes a heartwarming piece on Cohen’s life as a musician and examines his tryst with copyright. He notes that while Cohen lost all rights in his blockbuster song “Suzzane”, he took it like a sport and cherished the purity of the music and the moment. He also recounts Cohen’s forgiving and compassionate nature while dealing with a former manager-friend who ripped off the singer…


Read More »